Cargando…
Therapeutic reversal of Huntington’s disease by in vivo self-assembled siRNAs
Huntington’s disease is an autosomal-dominant neurodegenerative disease caused by CAG expansion in exon 1 of the huntingtin (HTT) gene. Since mutant huntingtin (mHTT) protein is the root cause of Huntington’s disease, oligonucleotide-based therapeutic approaches using small interfering RNAs (siRNAs)...
Autores principales: | Zhang, Li, Wu, Tengteng, Shan, Yangyang, Li, Ge, Ni, Xue, Chen, Xiaorui, Hu, Xiuting, Lin, Lishan, Li, Yongchao, Guan, Yalun, Gao, Jinfeng, Chen, Dingbang, Zhang, Yu, Pei, Zhong, Chen, Xi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8677541/ https://www.ncbi.nlm.nih.gov/pubmed/34918046 http://dx.doi.org/10.1093/brain/awab354 |
Ejemplares similares
-
Evaluation of Blood Glial Fibrillary Acidic Protein as a Potential Marker in Huntington's Disease
por: You, Huajing, et al.
Publicado: (2021) -
The First Patient with Sporadic Huntington’s Disease Due To a de Novo (CAG)n Expansion in China
por: Lin, Lishan, et al.
Publicado: (2022) -
Modular and hierarchical self-assembly of siRNAs into supramolecular nanomaterials for soft and homogeneous siRNA loading and precise and visualized intracellular delivery
por: Guan, Xiaowen, et al.
Publicado: (2022) -
ATP-activated decrosslinking and charge-reversal vectors for siRNA delivery and cancer therapy
por: Zhou, Zhanwei, et al.
Publicado: (2018) -
siRNA screen identifies QPCT as a druggable target for Huntington’s disease
por: Jimenez-Sanchez, Maria, et al.
Publicado: (2015)